Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

SYRESYRE
12 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in SPYRE THERAPEUTICS INC

WELLINGTON MANAGEMENT GROUP LLP holds 1.6M shares of SYRE (SPYRE THERAPEUTICS INC), worth $140.4M as of 2026-Q2. The position was decreased (-13.3% shares). SYRE represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$140.4M

Current Shares

1.6M

Total Value Change

+$136.7M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.6M
-13.3%
$140.4M0.0%$88.78
0
2026-Q1
Increased
1.8M
+17.8%
$92M0.0%$40.07
35
2025-Q4
Decreased
1.5M
-5.5%
$50.8M0.0%$31.88
0
2025-Q3
Increased
1.6M
+8.4%
$27.5M0.0%$16.36
31
2025-Q2
Decreased
1.5M
-5.0%
$22.7M0.0%$15.22
0
2025-Q1
Decreased
1.6M
-0.7%
$25.7M0.0%$17.94
0
2024-Q4
Increased
1.6M
+6.5%
$37.4M0.0%$22.54
31
2024-Q3
Increased
1.5M
+89.4%
$44.3M0.0%$28.49
46
2024-Q2
Decreased
795,946
-2.1%
$18.7M0.0%$23.51
0
2024-Q1
Increased
812,860
+27.9%
$30.8M0.0%$37.93
36
2023-Q4
Increased
635,455
+111.9%
$13.7M0.0%$21.52
45
2023-Q3
New
299,929
-
$3.7M0.0%$12.25
37

Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used